TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm

Benzinga Logo Benzinga By Business Wire
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating potential securities law violations by Anavex Life Sciences after the company received a negative trend vote from the European Medicines Agency on its blarcamesine marketing application, causing a significant stock price drop.

Insights
ARGX   positive

Board addition of co-founder and CEO Tim Van Hauwermeiren brings experienced leadership


AVXL   negative

Received a negative trend vote from EMA for marketing authorization, experienced a 35.9% stock price decline, and is now subject to a potential fraud investigation by the Schall Law Firm